Our News
Hepatitis B research using CN Bio Organ-on-Chips published in Nature Communications
London, UK, February 15 2018: In an article published in Nature Communications scientists at Imperial College London have demonstrated how pathogens interact with human organ mimics. The Organ-on-Chip technology used for the studies was an artificial liver -...
read moreR&D 100 Award won by Vanderbilt team for tech being developed with CN Bio
A cell-culture technology now being developed by London biotech CN Bio Innovations and its global pharmaceutical company partner, has won one of the scientific world's premier awards - known as the "Oscars of Innovation". A team of Vanderbilt University scientists and...
read moreCN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies
London, UK, November 1 2017: Organ-on-a-Chip specialist CN Bio Innovations Limited announces a research collaboration with global biopharmaceutical company AstraZeneca to validate a new in vitro research tool that enables the high throughput evaluation of multi-drug...
read moreFDA signs collaborative agreement with CN Bio Innovations to use Organs-on-Chips to improve drug development and evaluation
London, UK, October 26 2017: CN Bio Innovations Limited announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research. FDA and CN Bio will collaborate to...
read moreInnovate UK awards grant to CN Bio Innovations and AstraZeneca to use Organs-on-Chips to evaluate the use of existing drugs to treat fatty liver disease
London, UK, October 11 2017: Organ-on-a-Chip specialist CN Bio Innovations Limited announces that Innovate UK has awarded the company a £670,000 grant co-funded by the newly created Industrial Strategy Challenge Fund. Under the award, CN Bio will collaborate with...
read moreCN Bio Innovations announces licence of platform microfluidics technologies from Vanderbilt University
London, UK, October 10 2017: CN Bio Innovations Limited announces that it has licensed from Vanderbilt University three patents and applications, and software, covering microfluidics technologies relevant to the company’s Organs-on-Chips products and IP portfolio. The...
read moreCN Bio Innovations announces license of worldwide rights to Hepatitis B programme from Bristol-Myers Squibb
London, UK, April 5 2017: CN Bio Innovations Limited announces that it has licensed from Bristol-Myers Squibb Company a Hepatitis B drug discovery programme comprising several series of small molecule antiviral compounds. The exclusive agreement enables CN Bio to...
read moreHuffington Post features CN Bio
Huffington Post features CN Bio CEO: Women in Innovation: Developing 'Organs-on-Chips' Interview clip: "My background as a chemist means that I like precision. However, drug development is not nearly as logical as we’d like. Profound uncertainty about the likely...
read moreCN Bio featured on the Discovery Channel
Discovery Channel features CN Bio’s human-organ-on-a-chip platforms "Innovations" on the Discovery Channel has reported on CN Bio Innovations' technology which allows drug discovery scientists to understand with greater precision than ever before whether a new drug...
read moreDr Emma Sceats of organ-on-a-chip firm CN Bio Innovations wins Innovate UK’s infocus Women in Innovation award
Welwyn Garden City, UK- 15th November 2016: Following a nationwide competition, CEO of London bioengineering firm CN Bio Innovations Dr Emma Sceats has been named as a winner of Innovate UK’s infocus Women in Innovation award. The awards will be celebrated as part of...
read more